Skip to main content

and
  1. Article

    Open Access

    Prognostic value of HPV-PCR, p16 and p53 immunohistochemical status on local recurrence rate and survival in patients with vulvar squamous cell carcinoma

    The primary aim of this study was to assess the association between human papilloma virus (HPV) and p53 expression and local recurrence (LR), disease specific survival (DSS), and overall survival (OS) in patie...

    A. W. Pouwer, N. C. te Grootenhuis, F. Hinten, G. H. de Bock in Virchows Archiv (2024)

  2. Article

    Open Access

    Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3

    Assessment of DNA promoter methylation markers in cervical scra**s for the detection of cervical intraepithelial neoplasia (CIN) and cervical cancer is feasible, but finding methylation markers with both hig...

    A. Boers, R. Wang, R. W. van Leeuwen, H. G. Klip, G. H. de Bock in Clinical Epigenetics (2016)

  3. Article

    Open Access

    DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women

    Primary high-risk human papillomavirus (hrHPV) testing in cervical cancer screening shows relatively low specificity, which makes triage testing necessary. In this study, DNA methylation analysis was compared ...

    A Boers, R P Bosgraaf, R W van Leeuwen, E Schuuring in British Journal of Cancer (2014)

  4. Article

    Open Access

    Nutlin-3 preferentially sensitises wild-type p53-expressing cancer cells to DR5-selective TRAIL over rhTRAIL

    Tumour cell-selective activation of apoptosis by recombinant human TNF-related apoptosis-inducing ligand (rhTRAIL) is enhanced through co-activation of p53 by chemotherapeutic drugs. The novel anticancer agent...

    A Meijer, F A E Kruyt, A G J van der Zee, H Hollema, P Le in British Journal of Cancer (2013)

  5. Article

    Open Access

    Risk factors for short- and long-term complications after groin surgery in vulvar cancer

    The cornerstone of treatment in early-stage squamous cell carcinoma (SCC) of the vulva is surgery, predominantly consisting of wide local excision with elective uni- or bi-lateral inguinofemoral lymphadenectom...

    F Hinten, L C G van den Einden, J C M Hendriks in British Journal of Cancer (2011)

  6. No Access

    Article

    A bioinformatical and functional approach to identify novel strategies for chemoprevention of colorectal cancer

    Comparing normal colorectal mucosa and adenomas focusing on deregulated pathways obtains insight into the biological processes of early colorectal carcinogenesis. Publicly available microarray expression data ...

    D M Hei**k, R S N Fehrmann, E G E de Vries, J J Koornstra, D Oosterhuis in Oncogene (2011)

  7. Article

    Open Access

    Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis

    Drug resistance is a major problem in ovarian cancer. Triggering apoptosis using death ligands such as tumour necrosis factor-related apoptosis inducing ligand (TRAIL) might overcome chemoresistance.

    E W Duiker, A Meijer, A R M van der Bilt, G J Meersma, N Kooi in British Journal of Cancer (2011)

  8. Article

    Open Access

    Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer

    Tumour-infiltrating lymphocytes (TILs) are predictors of disease-specific survival (DSS) in ovarian cancer. It is largely unknown what factors contribute to lymphocyte recruitment. Our aim was to evaluate gene...

    N Leffers, R S N Fehrmann, M J M Gooden, U R J Schulze in British Journal of Cancer (2010)

  9. Article

    Open Access

    Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis

    P53, EGFR and HER-2/neu are the most frequently studied molecular biological parameters in epithelial ovarian cancer, but their prognostic impact is still unequivocal. We performed a meta-analysis to more prec...

    P de Graeff, A P G Crijns, S de Jong, M Boezen, W J Post in British Journal of Cancer (2009)

  10. Article

    Open Access

    The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer

    Ovarian cancer is the most frequent cause of death from gynaecological cancer in the Western world. Current prognostic factors do not allow reliable prediction of response to chemotherapy and survival for indi...

    P de Graeff, A P G Crijns, K A ten Hoor, H G Klip, H Hollema in British Journal of Cancer (2008)

  11. Article

    Open Access

    Reply: The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer

    P de Graeff, J Hall, A P G Crijns, G H de Bock, J Paul in British Journal of Cancer (2007)

  12. Article

    Open Access

    Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies

    The prognostic impact of p53 immunostaining in a large series of tumours from epithelial ovarian cancer patients in a two-centre study was analysed. The study population (n=476) comprised of a retrospective serie...

    P de Graeff, J Hall, A P G Crijns, G H de Bock, J Paul in British Journal of Cancer (2006)

  13. Article

    Open Access

    A phase I and pharmacokinetic study of intraperitoneal topotecan

    Purpose: To evaluate the feasibility and pharmacology of intraperitoneal (IP) topotecan. Patients and methods: Fifteen patients with recurrent ovarian cancer in a phase I trial were treated with escalating IP top...

    L S Hofstra, A M E Bos, E G E de Vries, A G J van der Zee in British Journal of Cancer (2001)

  14. Article

    Open Access

    Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation

    High-dose chemotherapy and peripheral blood stem cell transplantation (PBSCT) may accelerate telomere length loss in haematopoietic stem cells. As data including pre-and post-treatment samples are lacking, we ...

    C P Schröder, G B A Wisman, S de Jong, W T A van der Graaf in British Journal of Cancer (2001)

  15. Article

    Open Access

    Ovarian cysts in women receiving tamoxifen for breast cancer

    Tamoxifen is a nonsteroidal anti-oestrogen with gynaecological side-effects. Only recently, ovarian cyst formation during tamoxifen treatment has been reported. The present study aimed to evaluate patient-rela...

    M J E Mourits, E G E de Vries, P H B Willemse, K A ten Hoor in British Journal of Cancer (1999)

  16. Article

    Open Access

    DNA topoisomerase IIα and -β expression in human ovarian cancer

    To study DNA topoisomerase IIα (Topo-IIα) and -β expression and regulation in human ovarian cancer, 15 ovarian tumour samples were investigated. To compare different levels of expression, the samples were scre...

    S Withoff, A G J van der Zee, S de Jong, H Hollema, E F Smit in British Journal of Cancer (1999)